Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.

CEO

Lars Fruergaard Jørgensen

CEOLars Fruergaard Jørgensen

Employees

76,302

Employees76,302

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1931

Founded1931

Employees

76,302

Employees76,302

NVO Key Statistics

Market cap

354.70B

Market cap354.70B

Price-Earnings ratio

23.63

Price-Earnings ratio23.63

Dividend yield

1.48%

Dividend yield1.48%

Average volume

9.84M

Average volume9.84M

High today

$82.13

High today$82.13

Low today

$79.43

Low today$79.43

Open price

$81.41

Open price$81.41

Volume

7.49M

Volume7.49M

52 Week high

$148.15

52 Week high$148.15

52 Week low

$57.00

52 Week low$57.00

NVO News

Seeking Alpha 4d

Novo Nordisk taps Nvidia to accelerate drug discovery through AI

Nvidia (NASDAQ:NVDA) announced a collaboration with Novo Nordisk (NVO) (OTCPK:NONOF) on Wednesday to speed up the Danish pharma giant's efforts in drug discover...

Sherwood News 6d

Obesity treatment startup Metsera rises on positive trial results

Obesity treatment startup Metsera rises on positive trial results New York-based obesity treatment startup Metsera is up by double digits after it reported enc...

Analyst ratings

60%

of 30 ratings

Buy

60%

Hold

30%

Sell

10%